Humira (adalimumab) is a prescription medication used to treat several autoimmune and inflammatory conditions by targeting and neutralizing tumor necrosis factor (TNF), a protein involved in causing inflammation[1][7].
Its main approved uses include:
- Rheumatoid arthritis (RA): Used in adults to reduce signs and symptoms, may slow joint damage, and improve physical function[2][3][5].
- Psoriatic arthritis: Used in adults to reduce joint pain and skin symptoms associated with the condition[3][4][5].
- Ankylosing spondylitis: Used to manage active ankylosing spondylitis in adults[3][5].
- Juvenile idiopathic arthritis: Used in children (2 years and older) with moderately to severely active polyarticular juvenile idiopathic arthritis[3][5].
- Crohn’s disease: Indicated for adults and children (6 years and older) to reduce signs and symptoms, induce and maintain remission when other therapies have been inadequate[3][5].
- Ulcerative colitis: Used to treat moderate to severe cases in adults and children (5 years and older)[1].
- Plaque psoriasis: Used in adults with moderate to severe plaque psoriasis[1][3][7].
- Hidradenitis suppurativa: Used in people aged 12 years and older for this chronic skin condition[1][3].
- Uveitis: Used to treat non-infectious uveitis in adults and children aged 2 years and older[1][3].
References
- [1] Healthline – Humira Injection: Uses, Dosage, Side Effects, and More
- [2] HUMIRA for Moderate to Severe Rheumatoid Arthritis (RA)
- [3] Johns Hopkins Arthritis Center – Adalimumab (Humira®) Drug Information Sheet
- [4] HUMIRA® (adalimumab) for Psoriatic Arthritis
- [5] FDA Label – HUMIRA (adalimumab) Highlights of Prescribing Information
- [7] EMA – Humira | European Medicines Agency (EMA)